{"SLR NAME":"SISCoV study: systemic inflammatory syndrome in COVID-19 - a systematic review and meta-analysis of multisystem inflammatory syndrome in children with SARS-CoV-2 infection","References":[{"title1":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","References":[{"title2":"Nuovo coronavirus: cosa c'e da sapere","References":[]},{"title2":"Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries","References":[]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention"},{"title3":"Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies"},{"title3":"Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China"},{"title3":"[Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China]"},{"title3":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China"},{"title3":"SARS-CoV-2 infection in children: transmission dynamics and clinical characteristics"},{"title3":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures"},{"title3":"Clinical and ct features in pediatric patients with COVID-19 infection: different points from adults"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"ARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement"}]},{"title2":"Epidemiology of COVID-19 among children in China","References":[{"title3":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 83 [press release]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200412-sitrep-83-covid-19.pdf?sfvrsn=697ce98d_4. Accessed April 12, 2020."},{"title3":"Epidemiology of COVID-19 among children in China"},{"title3":"Control and Prevention. Coronavirus Disease 2019 in Children : United States, February 12-April 2, 2020"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"SARS-CoV-2 infection in children"},{"title3":"Detection of COVID-19 in children in early January 2020 in Wuhan, China"},{"title3":"Novel coronavirus infection in hospitalized infants under 1 year of age in China"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"A 55-day-old female infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage"},{"title3":"Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children"},{"title3":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection"}]},{"title2":"A pediatric emergency department protocol to avoid intra-hospital dispersal of SARS-CoV-2 during the outbreak in Bergamo, Italy","References":[]},{"title2":"Evidence for gastrointestinal infection of SARS-CoV-2","References":[{"title3":"Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"}]},{"title2":"On the alert for cytokine storm: immunopathology in COVID-19","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Clinical and immunologic features in severe and moderate coronavirus disease 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis"},{"title3":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome"},{"title3":"Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza"},{"title3":"A personalized diagnostic and treatment approach for macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in adults"},{"title3":"How we manage hyperferritinemic sepsis-related multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocytic lymphohistiocytosis histiocytosis"},{"title3":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial"},{"title3":"Chimeric antigen receptor T cells for sustained remissions in leukemia"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"Coronavirus disease (2019). Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19)"},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome"}]},{"title2":"Coronaviruses and immunosuppressed patients. The facts during the third epidemic","References":[{"title3":"Coronaviruses and immunosuppressed patients: the facts during the third epidemic"},{"title3":"COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy"},{"title3":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure"},{"title3":"Effects of antirejection drugs on innate immune cells after kidney transplantation"}]},{"title2":"COVID-19: consider cytokine storm syndromes and immunosuppression","References":[{"title3":"Coronavirus disease 2019 (COVID-19)situation report - 52"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Adult haemophagocytic syndrome"},{"title3":"Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis"},{"title3":"Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase iii trial"},{"title3":"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome"}]},{"title2":"A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan","References":[]},{"title2":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients","References":[]},{"title2":"Recognition of a Kawasaki disease shock syndrome","References":[{"title3":"Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 Nationwide survey"},{"title3":"Long-term prognostic impact of Dobutamine stress echocardiography in patients with Kawasaki disease and coronary artery lesions"},{"title3":"Recent advances in Kawasaki disease - proceedings of the 3rd Kawasaki disease summit, Chandigarh, 2014"},{"title3":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial"},{"title3":"A half-century of autopsy results--incidence of pediatric vasculitis syndromes, especially Kawasaki disease"},{"title3":"Atypical presentation of Kawasaki disease in an infant"},{"title3":"Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male"},{"title3":"Acute heart failure and acute renal failure in Kawasaki disease"},{"title3":"Kawasaki disease in a pediatric intensive care unit: a case-control study"},{"title3":"Recognition of a Kawasaki disease shock syndrome"},{"title3":"Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children"},{"title3":"Population-based study of Kawasaki disease shock syndrome in Taiwan"},{"title3":"Clinical manifestations of Kawasaki disease shock syndrome: a case-control study"},{"title3":"Ma L, Zhang YY, Yu HG. Clinical manifestations of Kawasaki disease shock syndrome. Clin Pediatr (Phila). 2018;57(4):428-35."},{"title3":"Describing Kawasaki shock syndrome: results from a retrospective study and literature review"},{"title3":"Infliximab is the new kid on the block in Kawasaki disease: a single-Centre study over 8 years from North India"},{"title3":"Diagnosis, treatment, and long-term Management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association"},{"title3":"Kawasaki disease: laboratory findings and an immuno-pathogenesis on the premise of a &quot;protein homeostasis system&quot;"},{"title3":"Clinical implications in laboratory parameter values in acute Kawasaki disease for early diagnosis and proper treatment"},{"title3":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association"},{"title3":"Kawasaki disease with Giant coronary aneurysms requiring a ventricular assist device to separate from extracorporeal membrane oxygenation: coronary issues can be a pediatric problem too!"},{"title3":"Overview of pharmacological treatment options for pediatric patients with refractory Kawasaki disease"},{"title3":"Clinical course and features in acute stage of Kawasaki disease"},{"title3":"Epidemiology of Kawasaki disease in Asia, Europe, and the United States"},{"title3":"Epidemiologic features of Kawasaki disease in Shanghai from 2008 through 2012"},{"title3":"Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome"},{"title3":"Sorting nexin 24 genetic variation associates with coronary artery aneurysm severity in Kawasaki disease patients"},{"title3":"Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease"},{"title3":"Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease"},{"title3":"Cerebral vasculitis in severe Kawasaki disease: early detection by magnetic resonance imaging and good outcome after intensive treatment"},{"title3":"IL-1 signaling is critically required in stromal cells in Kawasaki disease Vasculitis mouse model: role of both IL-1alpha and IL-1beta"},{"title3":"Role of Interleukin-1 signaling in a mouse model of Kawasaki disease-associated abdominal aortic aneurysm"},{"title3":"IL-1 inhibition may have an important role in treating refractory Kawasaki disease"},{"title3":"A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation"},{"title3":"The induction of cardioangitis by lactobacillus casei cell wall in mice. I. the cytokine production from murine macrophages by lactobacillus casei cell wall extract"},{"title3":"The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease"},{"title3":"T-helper cytokine profiles in patients with Kawasaki disease"},{"title3":"Limited diagnostic value of procalcitonin in early diagnosis of adult onset Still's disease"},{"title3":"Serum procalcitonin value is useful for predicting severity of Kawasaki disease"},{"title3":"Serum procalcitonin concentration in patients with Kawasaki disease"},{"title3":"Lack of value of procalcitonin for prediction of coronary aneurysms in Kawasaki disease"},{"title3":"Inflammation markers in point-of-care testing (POCT)"},{"title3":"Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis"},{"title3":"Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease"},{"title3":"Elevated levels of high-sensitivity C-reactive protein and serum amyloid-a late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease"},{"title3":"IL. 6 pathway in the liver: from physiopathology to therapy"},{"title3":"IL-10 polymorphisms are associated with coronary artery lesions in acute stage of Kawasaki disease"},{"title3":"Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease"},{"title3":"Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease"},{"title3":"The serum concentration of soluble interleukin-2 receptor in patients with Kawasaki disease"},{"title3":"TNF-alpha is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease"},{"title3":"High avidity cytokine autoantibodies in health and disease: pathogenesis and mechanisms"},{"title3":"Transcriptional analysis of intravenous immunoglobulin resistance in Kawasaki disease using an induced pluripotent stem cell disease model"},{"title3":"Macro creatine kinase in Kawasaki disease"},{"title3":"The clinical picture of severe systemic capillary-leak syndrome episodes requiring ICU admission"},{"title3":"Relationship between serum sodium level and coronary artery abnormality in Kawasaki disease"},{"title3":"High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome"},{"title3":"Beneficial effect of intravenous immunoglobulins on systemic capillary leak syndrome in patients with monoclonal gammopathy"},{"title3":"Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors"},{"title3":"Posttranscriptional regulation of T-cell IL-2 production by human pooled immunoglobin"},{"title3":"Comparison of Th1/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis"},{"title3":"Prognostic factors of early death in children with hemophagocytic lymphohistiocytosis"}]},{"title2":"Macrophage activation syndrome in Kawasaki disease: more common than we thought?","References":[]},{"title2":"Is Kawasaki disease an infectious disorder?","References":[{"title3":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association"},{"title3":"Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey"},{"title3":"Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007"},{"title3":"Temporal and geographical clustering of Kawasaki disease in Japan: 2007-2012"},{"title3":"Kawasaki syndrome: description of two outbreaks in the United States"},{"title3":"An epidemic of Kawasaki syndrome in Hawaii"},{"title3":"Outbreak of Kawasaki syndrome in Finland"},{"title3":"Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86"},{"title3":"Epidemiology of Kawasaki disease in Asia, Europe, and the United States"},{"title3":"Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight"},{"title3":"Postnatal Risk of Acquiring Kawasaki Disease: A Nationwide Birth Cohort Database Study"},{"title3":"The search for the etiology of Kawasaki disease"},{"title3":"Kawasaki Disease and Exposure to Fine Particulate Air Pollution"},{"title3":"Association of Kawasaki disease with tropospheric wind patterns"},{"title3":"Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan"},{"title3":"Predicting the characteristics of the aetiological agent for Kawasaki disease from other paediatric infectious diseases in Japan"},{"title3":"Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study"},{"title3":"General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations"},{"title3":"IgA plasma cells in vascular tissue of patients with Kawasaki syndrome"},{"title3":"IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease"},{"title3":"Molecular biology, pathogenesis and pathology of mumps virus"},{"title3":"Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season"},{"title3":"Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases"},{"title3":"Pathologic findings in twelve fatal cases of toxic shock syndrome"},{"title3":"CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease"},{"title3":"Characterization of T cell repertoire changes in acute Kawasaki disease"},{"title3":"Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease"},{"title3":"TCR V beta family repertoire and T cell activation markers in Kawasaki disease"},{"title3":"Characterization of the T-cell receptor V-beta repertoire in Kawasaki disease"},{"title3":"Oligoclonal IgA response in the vascular wall in acute Kawasaki disease"},{"title3":"Clonal expansion of CD8+ T cells in Kawasaki disease"},{"title3":"Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody"},{"title3":"Cloning the arterial IgA antibody response during acute Kawasaki disease"},{"title3":"RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease"},{"title3":"Proteomic developments in the analysis of formalin-fixed tissue"},{"title3":"Virus characterization and discovery in formalin-fixed paraffin-embedded tissues"},{"title3":"Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies are not increased in Kawasaki disease"},{"title3":"No autoantibodies to nuclear antigens in the Kawasaki syndrome"},{"title3":"The transcriptional profile of coronary arteritis in Kawasaki disease"},{"title3":"Kawasaki disease: a matter of innate immunity"},{"title3":"Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease"},{"title3":"Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a &quot;new&quot; virus associated with Kawasaki disease"},{"title3":"Finding the cause of Kawasaki disease: a pediatric infectious diseases research priority"},{"title3":"Gene-expression patterns reveal underlying biological processes in Kawasaki disease"},{"title3":"Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection"},{"title3":"Kawasaki Disease at 50 Years"}]},{"title2":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","References":[]},{"title2":"2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","References":[]},{"title2":"Kawasaki disease complicated with macrophage activation syndrome: a systematic review","References":[]},{"title2":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial","References":[]},{"title2":"Kawasaki disease: insights into pathogenesis and approaches to treatment","References":[]},{"title2":"Kawasaki disease: epidemiology and the lessons from it","References":[]},{"title2":"Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey","References":[{"title3":"Advances in Kawasaki disease"},{"title3":"Kawasaki disease"},{"title3":"Intercostal artery aneurysm in a child with Kawasaki disease and known coronary artery aneurysms"},{"title3":"Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)"},{"title3":"Long-term prognosis of Kawasaki disease: increased cardiovascular risk?"},{"title3":"Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease"},{"title3":"Acute coronary syndrome in adult patients with coronary artery lesions caused by Kawasaki disease: review of case reports"},{"title3":"Yanagawa H, Nakamura Y, Yashiro M, Kawasaki T, editors. Epidemiology of Kawasaki disease: a 30-year achievement. Tokyo: Shindan-to-Chiryosha; 2004."},{"title3":"Incidence of Kawasaki Disease in Japan: the Nationwide Surveys of 1999-2002"},{"title3":"Increasing incidence rate of Kawasaki disease in Japan: the nationwide survey"},{"title3":"Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006"},{"title3":"Monthly observation of the numbers of patients and incidence rates of Kawasaki disease in Japan: chronological and geographical observation from nationwide surveys"},{"title3":"Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2007-2008"},{"title3":"Yanagawa H. Summary of epidemiologic studies on Kawasaki disease in Japan. In: Yanagawa H, Nakamura Y, Yashiro M, Kawasaki T, editors. Epidemiology of Kawasaki disease: a 30-year achievement. Tokyo: Shindan-to-Chiryosha; 2004. p. 33-44."},{"title3":"Yanagawa H, Sonobe T. Cahnges in the diagnostic guidelines for Kawasaki disease. In: Yanagawa H, Nakamura Y, Yashiro M, Kawasaki T, editors. Epidemiology of Kawasaki disease: a 30-year achievement. Tokyo: Shindan-to-Chiryosha; 2004. p. 24-32."},{"title3":"Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labour and Welfare. Vital statistics of Japan, 2009 volume 1. Tokyo: Health and Welfare Statistics Association; 2011. p. 517-25."},{"title3":"An analysis of the number of patients with Kawasaki disease in Tochigi: using the data of the nationwide epidemiologic incidence survey and the public aid in Tochigi prefecture"},{"title3":"The 2011 magnitude 9.0 Tohoku-Oki earthquake: mosaicking the megathrust from seconds to centuries"},{"title3":"The 2009 A (H1N1) influenza virus pandemic: A review"},{"title3":"Yashiro M, Nakamura Y, Yanagawa H. An outline of the results of the 16th nationeide survey of Kawasaki disease. In: Yanagawa H, Nakamura Y, Yashiro M, Kawasaki T, editors. Epidemiology of Kawasaki disease: a 30-year achievement. Tokyo: Shindan-to-Chiryosha; 2004. p. 97-113."},{"title3":"Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labour and Welfare. Vital statistics of Japan, 2009 volume 1. Tokyo: Health and Welfare Statistics Association; 2011. p. 94-143."},{"title3":"Kawasaki disease in families"},{"title3":"Kawasaki disease in dizygotic twins in Turkey"},{"title3":"State-of-the-art basic and clinical science of Kawasaki disease: the 9th International Kawasaki Disease Symposium 10-12 April 2008, Taipei, Taiwan"},{"title3":"Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006"}]},{"title2":"Update on Kawasaki disease: epidemiology, aetiology and pathogenesis","References":[]},{"title2":"Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey","References":[{"title3":"Epidemiologic features of Kawasaki disease in Japan: Results of the 2009-2010 nationwide survey"},{"title3":"Advances in Kawasaki disease"},{"title3":"Kawasaki disease"},{"title3":"Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan"},{"title3":"Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)"},{"title3":"Long-term prognosis of Kawasaki disease: increased cardiovascular risk?"},{"title3":"Acute coronary syndrome in adult patients with coronary artery lesions caused by Kawasaki disease: review of case reports"},{"title3":"Guidelines for medical treatment of acute Kawasaki disease: report of the research committee of the Japanese society of pediatric cardiology and cardiac surgery (2012 revised version)"},{"title3":"Intercostal artery aneurysm in a child with Kawasaki disease and known coronary artery aneurysms"},{"title3":"Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease"},{"title3":"Yanagawa H. Summary of epidemiologic studies on Kawasaki disease in Japan. In: Yanagawa H, Nakamura Y, Yashiro M, Kawasaki T, editors. Epidemiology of Kawasaki disease: a 30-year achievement. Tokyo: Shindan-to-Chiryosha; 2004. p. 33-44."},{"title3":"Yanagawa H, Sonobe T. Changes in the diagnostic guidelines for Kawasaki disease. In: Yanagawa H, Nakamura Y, Yashiro M, Kawasaki T, editors. Epidemiology of Kawasaki disease: a 30-year achievement. Tokyo: Shindan-to-Chiryosha; 2004. p. 24-32."},{"title3":"Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labour and Welfare. Vital statistics of Japan, 2009 volume 1. Tokyo: Health and Welfare Statistics Association; 2011. p. 517-25."},{"title3":"Yanagawa H, Nakamura Y, Yashiro M, Kawasaki T, editors. Epidemiology of Kawasaki disease: a 30-year achievement. Tokyo: Shindan-to-Chiryosha; 2004."},{"title3":"Incidence of Kawasaki disease in Japan: the nationwide surveys of 1999-2002"},{"title3":"Increasing incidence of Kawasaki disease in Japan: nationwide survey"},{"title3":"Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006"},{"title3":"Monthly observation of the numbers of patients and incidence rates of Kawasaki disease in Japan: chronological and geographical observation from nationwide surveys"},{"title3":"Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2007-2008"},{"title3":"An analysis of the number of patients with Kawasaki disease in Tochigi: using the data of the nationwide epidemiologic incidence survey and public aid in Tochigi prefecture"},{"title3":"The 2009 A (H1N1) influenza virus pandemic: a review"},{"title3":"Mortality among Japanese with a history of Kawasaki disease: results at the end of 2009"},{"title3":"State-of-the-art basic and clinical science of Kawasaki disease: the 9th International Kawasaki Disease Symposium 10-12 April 2008, Taipei, Taiwan"},{"title3":"Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006"},{"title3":"Parents with history of Kawasaki disease whose child also had the same disease"},{"title3":"Kawasaki disease in families"}]},{"title2":"The genetics of Kawasaki disease","References":[]},{"title2":"Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007","References":[]},{"title2":"Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase","References":[{"title3":"Diagnosis, treatment, and long-term Management of Kawasaki Disease, a scientific statement for health professionals from the American heart"},{"title3":"2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides"},{"title3":"Acute febrile mucocutaneus syndrome with lymphoid involvement with specific desquamation of the finger and toes in children"},{"title3":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients"},{"title3":"Diagnosis and therapy of Kawasaki disease in children"},{"title3":"Diagnosis, treatment, and long-term management in Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young"},{"title3":"Epidemiology of Kawasaki disease in Asia, Europe, and the United States"},{"title3":"Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011"},{"title3":"The epidemiology and clinical features of Kawasaki disease in Australia"},{"title3":"Kawasaki disease in Israel"},{"title3":"The epidemiology of Kawasaki disease: a global update"},{"title3":"A two-year survey of mucocutaneous lymph node syndrome in north-eastern Italy. Epidemiological and clinical findings"},{"title3":"Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey"},{"title3":"Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas"},{"title3":"Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications"},{"title3":"Rising incidence of Kawasaki disease in England: analysis of hospital admission data"},{"title3":"Epidemiological features of Kawasaki disease in Taiwan, 1976-2007: results of five nationwide questionnaire hospital surveys"},{"title3":"Changes of clinical characteristics and outcomes in patients with Kawasaki disease over the past 7 years in a single center study"},{"title3":"Kawasaki syndrome and factors associated with coronary artery abnormalities in California"},{"title3":"Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China"},{"title3":"Seasonality of Kawasaki disease: a global perspective"},{"title3":"Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan"},{"title3":"Prevalence of coronary artery abnormality in incomplete Kawasaki disease"},{"title3":"Complete and incomplete Kawasaki disease: two sides of the same coin"},{"title3":"Kawasaki disease in families"},{"title3":"Familial occurrence of Kawasaki syndrome in North America"},{"title3":"Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 Nationwide survey"},{"title3":"Epidemiological features of Kawasaki disease in Korea, 2006-2008"},{"title3":"Genetic analysis of Kawasaki syndrome"},{"title3":"Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan"},{"title3":"Kawasaki disease in parents and children"},{"title3":"Parents with a history of Kawasaki disease whose child also had the same disease"},{"title3":"Long-term cardiovascular outcomes in survivors of Kawasaki disease"},{"title3":"Epidemiologic features and prognostic factors of coronary artery lesions associated with Kawasaki disease based on a 13-year cohort of consecutive cases identified by complete enumeration surveys in Wakayama, Japan"},{"title3":"Characteristics of Kawasaki disease in infants younger than six months of age"},{"title3":"Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome"},{"title3":"Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database"},{"title3":"Mortality among Japanese with a history of Kawasaki disease: results at the end of 2009"},{"title3":"Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey"},{"title3":"Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006"},{"title3":"Epidemiologic study on Kawasaki disease Beijing from 2000 through 2004"},{"title3":"Epidemiologic features of Kawasaki disease in Shanghai from 2003 through 2007"},{"title3":"Kawasaki disease in Hong Kong, 1994 to 2000"},{"title3":"Epidemiological study of Kawasaki disease in Sichuan province of China"},{"title3":"Is Kawasaki disease incidence rising in Chandigarh, North India?"},{"title3":"Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand"},{"title3":"Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii"},{"title3":"Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006"},{"title3":"Rising hospitalization rates of Kawasaki disease in Chile between 2001 and 2007"},{"title3":"Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens"},{"title3":"Kawasaki syndrome hospitalizations in Ireland, 1996 through 2000"},{"title3":"Kawasaki disease in Finland in 1982-1992"},{"title3":"Kawasaki syndrome in Denmark"},{"title3":"Kawasaki disease in Sweden: incidence and clinical features"},{"title3":"Increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography"},{"title3":"Kawasaki disease: insights into pathogenesis and approaches to treatment"},{"title3":"Kawasaki disease-specific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms"},{"title3":"Kawasaki disease with particular emphasis on arterial lesions"},{"title3":"Intravenous gamma-globulin treatment in Kawasaki disease"},{"title3":"An evaluation of the validity of the animal models of Kawasaki disease vasculopathy"},{"title3":"Kawasaki disease: basic and pathological findings"},{"title3":"Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease"},{"title3":"Oxidative stress and defective platelet apoptosis in naive patients with Kawasaki disease"},{"title3":"Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease"},{"title3":"Neutrophils scan for activated platelets to initiate inflammation"},{"title3":"PRR-signaling pathways: learning from microbial tactics"},{"title3":"Pattern recognition receptor function in neutrophils"},{"title3":"The inflammatory role of platelets via their TLRs and Siglec receptors"},{"title3":"Resolution of acute inflammation bridges the gap between innate and adaptive immunity"},{"title3":"The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease"},{"title3":"Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease"},{"title3":"Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease"},{"title3":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases"},{"title3":"Lack of CD4+CD25+FOXP3+ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease"},{"title3":"The role of TGF-beta and myofibroblasts in the arteritis of Kawasaki disease"},{"title3":"Genetics of Kawasaki disease: what we know and don't know"},{"title3":"CD40 gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population"},{"title3":"Update of genetic susceptibility in patients with Kawasaki disease"},{"title3":"Pustular rash in Kawasaki syndrome"},{"title3":"Retropharyngeal edema: an unusual manifestation of Kawasaki disease"},{"title3":"Risk factors for retropharyngeal cellulitis in Kawasaki disease"},{"title3":"Necrotic lesions of the face in Kawasaki disease"},{"title3":"Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis"},{"title3":"Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease"},{"title3":"Widened coronary arteries in a feverish child"},{"title3":"Coronary artery dilation in acute Kawasaki disease and acute illnesses associated with fever"},{"title3":"Coronary artery dimensions in febrile children without Kawasaki disease"},{"title3":"Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study"},{"title3":"Medium-size-vessel vasculitis"},{"title3":"Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research"},{"title3":"Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience"},{"title3":"Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease"},{"title3":"Macrophage activation syndrome in Kawasaki disease: more common than we thought?"},{"title3":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile arthritis"},{"title3":"Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki"},{"title3":"Recognition of a Kawasaki disease shock syndrome"},{"title3":"Clinical features of recurrent Kawasaki disease and its risk factors"},{"title3":"Autoinflammatory syndromes behind the scenes of recurrent fevers in children"},{"title3":"Altered lipid profile after Kawasaki syndrome"},{"title3":"Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis"},{"title3":"Endothelial dysfunction late after Kawasaki disease"},{"title3":"Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?"},{"title3":"Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease"},{"title3":"Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness"},{"title3":"Does oxidative stress play a critical role in cardiovascular complications of Kawasaki disease?"},{"title3":"The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases"},{"title3":"Coronary artery dimensions may be missclassified as normal in Kawasaki disease"},{"title3":"Pediatric Heart Network Investigators. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements"},{"title3":"Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki disease (JCS 2013)"},{"title3":"Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease"},{"title3":"Standard method for ultrasound imaging of coronary artery in children"},{"title3":"Ultrasound tissue characterization of the myocardium in patients after Kawasaki disease"},{"title3":"Application of prospective ECG-triggered dual-source CT coronary angiography for infants and children with coronary artery aneurysms due to Kawasaki disease"},{"title3":"Comparison study of echocardiography and dual-source CT in diagnosis of coronary artery aneurysm due to Kawasaki disease: coronary artery disease"},{"title3":"Ntsinjana HN, Tann O, Hughes M, Derrick G, Secinaro A, Schievano S, et al. Utility of adenosine stress perfusion CMR to assess paediatric coronary artery disease. Eur Heart J Cardiovasc Imaging. 2016; Epub ahead of print"},{"title3":"Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease"},{"title3":"Coronary artery abnormalities in Kawasaki disease: comparison between CT and MR coronary angiography"},{"title3":"Kawasaki Disease"},{"title3":"Evaluation of myocardial deformation in patients with Kawasaki disease using speckle-tracking echocardiography during mid-term follow-up"},{"title3":"Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nation-wide survey"},{"title3":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease"},{"title3":"Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance"},{"title3":"High-dose intravenous gammaglobulin for Kawasaki disease"},{"title3":"The treatment of Kawasaki syndrome with intravenous gamma globulin"},{"title3":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome"},{"title3":"Intravenous immunoglobulin for the treatment of Kawasaki disease in children"},{"title3":"Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease"},{"title3":"Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease"},{"title3":"Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment"},{"title3":"Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms"},{"title3":"Early treatment with intravenous immunoglobulin in patients with Kawasaki disease"},{"title3":"Diagnosis and treatment of suspected Kawasaki disease before the fifth day of illness"},{"title3":"Intravenous immunoglobulin: adverse reactions and management"},{"title3":"Anti-inflammatory actions of intravenous immunoglobulin"},{"title3":"Guidelines for medical treatment of acute Kawasaki disease: Report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version)"},{"title3":"Management of Kawasaki disease"},{"title3":"Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose"},{"title3":"Critical overview of the risk scoring systems to predict non-responsiveness to intravenous immunoglobulin in Kawasaki syndrome"},{"title3":"Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007"},{"title3":"Childhood vaccines and Kawasaki disease. Vaccine safety datalink, 1996-2006"},{"title3":"The role of infection in Kawasaki syndrome"},{"title3":"Aspirin and Reye syndrome"},{"title3":"Kawasaki disease and immunisation: standardised case definition &amp; guidelines for data collection, analysis"},{"title3":"Vaccines and Kawasaki disease"},{"title3":"Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations"},{"title3":"EULAR recommendations for vaccination in paediatric patients with rheumatic diseases"},{"title3":"Vaccination of children and adolescents with rheumatic diseases"},{"title3":"Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis"},{"title3":"Vaccination recommendations for patients with neuromuscular disease"}]},{"title2":"Association between a novel human coronavirus and Kawasaki disease","References":[]},{"title2":"Coronaviruses in the limelight","References":[]},{"title2":"Lack of association between New Haven coronavirus and Kawasaki disease","References":[{"title3":"Identification of a new human coronavirus"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Detection of human coronavirus NL63 in young children with bronchiolitis"},{"title3":"New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia"},{"title3":"Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children"},{"title3":"Association between a novel human coronavirus and Kawasaki disease"}]},{"title2":"Reply to van der Hoek and Berkhout, Ebihara et al., and Belay et al","References":[]},{"title2":"Concurrent respiratory viruses and Kawasaki disease","References":[]},{"title2":"Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease","References":[]},{"title2":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","References":[{"title3":"A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Systemic Juvenile Idiopathic arthritis-associated lung disease: characterization and risk factors"},{"title3":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis"},{"title3":"Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups"},{"title3":"COVID-19 infection and rheumatoid arthritis: Faraway, so close!"},{"title3":"The immunology of macrophage activation syndrome"},{"title3":"Macrophage activation and polarization"},{"title3":"Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment"},{"title3":"Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine"},{"title3":"An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis"},{"title3":"Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis"},{"title3":"Macrophage activation syndrome: different mechanisms leading to a one clinical syndrome"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China"},{"title3":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)"},{"title3":"Anakinra in children and adults with Still's disease"},{"title3":"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis"},{"title3":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial"},{"title3":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis under treatment with Tocilizumab"},{"title3":"A pathological report of three COVID-19 cases by minimally invasive autopsies"},{"title3":"Into the eye of the cytokine storm"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A proposed classification of the immunological diseases"},{"title3":"How should we approach classification of autoinflammatory diseases?"},{"title3":"Primary hemophagocytic lymphohistiocytosis and macrophage activation syndrome: the importance of timely clinical differentiation"},{"title3":"Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections"},{"title3":"Blockade of IL-6 &lt;em&gt;trans&lt;/em&gt; Signaling attenuates pulmonary fibrosis"},{"title3":"Interleukin-6 trans-signalling in chronic inflammation and cancer"},{"title3":"Dissecting Interleukin-6 classic- and trans-signaling in inflammation and cancer"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Covid-19 : the search for effective therapy"},{"title3":"Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model"},{"title3":"Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis"},{"title3":"Targeting interleukin 18 with interleukin 18 binding protein"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Primary and secondary hemophagocytic lymphohistiocytosis: clinical features"},{"title3":"Effect of IL-6 deficiency on susceptibility to HSV-1 respiratory infection and intrinsic macrophage antiviral resistance"},{"title3":"Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury"}]},{"title2":"COVID-19 in children and altered inflammatory responses","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]}]},{"title1":"Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City","References":[{"title2":"Epidemiology of COVID-19 Among Children in China","References":[{"title3":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 83 [press release]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200412-sitrep-83-covid-19.pdf?sfvrsn=697ce98d_4. Accessed April 12, 2020."},{"title3":"Epidemiology of COVID-19 among children in China"},{"title3":"Control and Prevention. Coronavirus Disease 2019 in Children : United States, February 12-April 2, 2020"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"SARS-CoV-2 infection in children"},{"title3":"Detection of COVID-19 in children in early January 2020 in Wuhan, China"},{"title3":"Novel coronavirus infection in hospitalized infants under 1 year of age in China"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"A 55-day-old female infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage"},{"title3":"Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children"},{"title3":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection"}]},{"title2":"Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 (COVID-19) at a tertiary care medical center in New York City","References":[]},{"title2":"Severe COVID-19 in Children and Young Adults in the Washington, DC Metropolitan Region","References":[]},{"title2":"Hyperinflammatory shock in children during COVID-19 pandemic","References":[{"title3":"Clinical analysis of Kawasaki disease shock syndrome"},{"title3":"The science underlying COVID-19: implications for the cardiovascular system"},{"title3":"Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN- as biomarkers for early recognition"}]},{"title2":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","References":[{"title3":"Nuovo coronavirus: cosa c'e da sapere"},{"title3":"Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection"},{"title3":"Epidemiology of COVID-19 among children in China"},{"title3":"A pediatric emergency department protocol to avoid intra-hospital dispersal of SARS-CoV-2 during the outbreak in Bergamo, Italy"},{"title3":"Evidence for gastrointestinal infection of SARS-CoV-2"},{"title3":"On the alert for cytokine storm: immunopathology in COVID-19"},{"title3":"Coronaviruses and immunosuppressed patients. The facts during the third epidemic"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan"},{"title3":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients"},{"title3":"Recognition of a Kawasaki disease shock syndrome"},{"title3":"Macrophage activation syndrome in Kawasaki disease: more common than we thought?"},{"title3":"Is Kawasaki disease an infectious disorder?"},{"title3":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association"},{"title3":"2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative"},{"title3":"Kawasaki disease complicated with macrophage activation syndrome: a systematic review"},{"title3":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial"},{"title3":"Kawasaki disease: insights into pathogenesis and approaches to treatment"},{"title3":"Kawasaki disease: epidemiology and the lessons from it"},{"title3":"Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey"},{"title3":"Update on Kawasaki disease: epidemiology, aetiology and pathogenesis"},{"title3":"Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey"},{"title3":"The genetics of Kawasaki disease"},{"title3":"Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007"},{"title3":"Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase"},{"title3":"Association between a novel human coronavirus and Kawasaki disease"},{"title3":"Coronaviruses in the limelight"},{"title3":"Lack of association between New Haven coronavirus and Kawasaki disease"},{"title3":"Reply to van der Hoek and Berkhout, Ebihara et al., and Belay et al"},{"title3":"Concurrent respiratory viruses and Kawasaki disease"},{"title3":"Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease"},{"title3":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease"},{"title3":"COVID-19 in children and altered inflammatory responses"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"}]},{"title2":"Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic","References":[]},{"title2":"Health advisory: pediatric multi-system inflammatory syndrome temporally associated with COVID-19 interim case definition in New York State","References":[]},{"title2":"Emergency preparedness and response","References":[]},{"title2":"Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department","References":[{"title3":"Epidemiology of COVID-19 among children in China"},{"title3":"Luo XP. [facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives]"},{"title3":"COVID-19 cytokine storm: the interplay between inflammation and coagulation"},{"title3":"Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome"}]},{"title2":"The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"Myocarditis associated with influenza A H1N1pdm2009"},{"title3":"Coronavirus associated fulminant myocarditis successfully treated with intravenous immunoglobulin and extracorporeal membrane oxygenation"},{"title3":"Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus"},{"title3":"Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada"},{"title3":"Cardiovascular complications of severe acute respiratory syndrome"},{"title3":"Frequency and consequences of influenza vaccination in adults with congenital heart disease"},{"title3":"Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association"},{"title3":"Human coronavirus NL-63 infections in children: a 1-year study"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS"},{"title3":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia"},{"title3":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): a Chinese perspective"},{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"},{"title3":"Presumed asymptomatic carrier transmission of COVID-19"},{"title3":"Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020"},{"title3":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (COVID-19)"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state"},{"title3":"SARS-CoV-2: a potential novel etiology of fulminant myocarditis"},{"title3":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin"},{"title3":"An experimental model for dilated cardiomyopathy after rabbit coronavirus infection"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"First cases of COVID-19 in heart transplantation from China"},{"title3":"Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China"},{"title3":"SARS-CoV-2 infection in children"},{"title3":"Novel coronavirus infection and pregnancy"},{"title3":"Sensitivity of chest CT for COVID-19: comparison to RT-PCR"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Coronavirus Disease 2019 (COVID-19). &quot;How to Protect Yourself&quot;"},{"title3":"Bulletin ACCC. COVID-19 Clinical Guidance For the Cardiovascular Care Team. 1-4."},{"title3":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) : United States, February 12-March 16, 2020"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (7th edition) [Internet]. Available from: http://kjfy.meetingchina.org/msite/news/show/cn/3337.html"},{"title3":"Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore"},{"title3":"Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev. Res. 2020;(February):2-5."},{"title3":"de Simone G. Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers [Internet]. 2020 [cited 2020 Mar 20]. Available from: https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang"}]},{"title2":"Acute myocarditis and pericarditis in children","References":[]},{"title2":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"SARS: epidemiology"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"Clinical management and infection control of SARS: lessons learned"},{"title3":"Coronaviruses:drug discovery and therapeutic options"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic Betacoronavirus causing SARS-like disease"},{"title3":"Middle East respiratory syndrome"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant"},{"title3":"Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus"},{"title3":"Inhibitors of the hepatitis C virus polymerase; mode of action and resistance"},{"title3":"Approved antiviral drugs over the past 50 years"},{"title3":"Discovery of an RNA virus 3' 5' exoribonuclease that is critically involved in coronavirus RNA synthesis"},{"title3":"High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants"},{"title3":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"BCX4430:a broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease"},{"title3":"Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-CoV)"},{"title3":"SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets"},{"title3":"Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides"},{"title3":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430"},{"title3":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"The mechanism of action of beta-d-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-d-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"Coronaviruses: an overview of their replication and pathogenesis"},{"title3":"A time-of-drug addition approach to target identification of antiviral compounds"},{"title3":"Homology-based identification of a mutation in the coronavirus RNA-dependent RNA polymerase that confers resistance to multiple mutagens"},{"title3":"Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design"},{"title3":"A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity"},{"title3":"Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro"},{"title3":"Arbovirus high fidelity variant loses fitness in mosquitoes and mice"},{"title3":"The M184 V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen"},{"title3":"Inhibition of human coronavirus NL63 infection at early stages of the replication cycle"},{"title3":"Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase"},{"title3":"T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro"},{"title3":"Mechanism of action of ribavirin in the treatment of chronic hepatitis C"},{"title3":"Mechanism of action of 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole), a new broad-spectrum antiviral agent"},{"title3":"Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate"},{"title3":"Sequential structures provide insights into the fidelity of RNA replication"},{"title3":"Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase"},{"title3":"Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1"},{"title3":"One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities"},{"title3":"Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA"},{"title3":"L159F and V321A sofosbuvir-associated hepatitis C virus NS5B substitutions"},{"title3":"Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice"},{"title3":"In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine"},{"title3":"Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59"},{"title3":"Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells"},{"title3":"Well-differentiated human airway epithelial cell cultures"},{"title3":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus"},{"title3":"Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus"}]},{"title2":"The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality","References":[]},{"title2":"Intravenous immunoglobulin in neurology--mode of action and clinical efficacy","References":[]},{"title2":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","References":[]}]},{"title1":"Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases","References":[{"title2":"Tagarro A et al. JAMA Pediatr. https://doi.org/10.1001/jamapediatrics.2020.1346. Accessed May 28, 2020.","References":[]}]},{"title1":"Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know","References":[{"title2":"Public health approach to emerging infections among pregnant women","References":[]},{"title2":"Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States","References":[]},{"title2":"Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians","References":[{"title3":"Zika virus"},{"title3":"First report of autochthonous transmission of Zika virus in Brazil"},{"title3":"Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy - Brazil, 2015"},{"title3":"Zika virus and birth defects-reviewing the evidence for causality"},{"title3":"Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study"},{"title3":"Initial description of the presumed congenital Zika syndrome"},{"title3":"Zika fever and congenital Zika syndrome: An unexpected emerging arboviral disease"},{"title3":"Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation"},{"title3":"Clinical and imaging findings in an infant with zika embryopathy"},{"title3":"Cranial bone collapse in microcephalic infants prenatally exposed to Zika virus infection"},{"title3":"Zika virus infection with prolonged maternal viremia and fetal brain abnormalities"},{"title3":"Sensorineural hearing loss in a case of congenital Zika virus"},{"title3":"Zika virus associated with microcephaly"},{"title3":"Microcephaly associated with maternal Zika virus infection"},{"title3":"Prolonged shedding of zika virus associated with congenital infection"},{"title3":"Confirmed case of Zika virus congenital infection, Spain, March 2016"},{"title3":"Zika virus in Brazil and macular atrophy in a child with microcephaly"},{"title3":"Intrauterine Zika virus infection and microcephaly: correlation of perinatal imaging and three-dimensional virtual physical models"},{"title3":"First trimester intrauterine Zika virus infection and brain pathology: prenatal and postnatal neuroimaging findings"},{"title3":"Congenital cerebral malformations and dysfunction in fetuses and newborns following the 2013 to 2014 Zika virus epidemic in French Polynesia"},{"title3":"Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study"},{"title3":"Microcephaly and Zika virus: neonatal neuroradiological aspects"},{"title3":"Clinical features and neuroimaging (CT and MRI) findings in presumed Zika virus related congenital infection and microcephaly: retrospective case series study"},{"title3":"Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil"},{"title3":"Prenatal brain MRI of fetuses with Zika virus infection"},{"title3":"Computed tomographic findings in microcephaly associated with Zika virus"},{"title3":"Hearing loss in infants with microcephaly and evidence of congenital Zika virus infection - Brazil, November 2015-May 2016"},{"title3":"Pathology of congenital Zika syndrome in Brazil: a case series"},{"title3":"Microcephaly in Infants, Pernambuco State, Brazil, 2015"},{"title3":"Expanded spectrum of congenital ocular findings in microcephaly with presumed Zika infection"},{"title3":"Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg?"},{"title3":"Progressive lesions of central nervous system in microcephalic fetuses with suspected congenital Zika virus syndrome"},{"title3":"Possible association between Zika virus infection and microcephaly : Brazil, 2015"},{"title3":"Early growth and neurologic outcomes of infants with probable congenital Zika virus syndrome"},{"title3":"Congenital brain abnormalities and Zika virus: what the radiologist can expect to see prenatally and postnatally"},{"title3":"Fetal infection by Zika virus in the third trimester - report of 2 cases"},{"title3":"Congenital Zika syndrome with arthrogryposis: retrospective case series study"},{"title3":"Risk factors associated with the ophthalmoscopic findings identified in infants with presumed Zika virus congenital infection"},{"title3":"Ophthalmological findings in infants with microcephaly and presumable intra-uterus Zika virus infection"},{"title3":"Zika virus infection in pregnant women in Rio de Janeiro - preliminary report"},{"title3":"In utero brain destruction resulting in collapse of the fetal skull, microcephaly, scalp rugae, and neurologic impairment: the fetal brain disruption sequence"},{"title3":"Report and review of the fetal brain disruption sequence"},{"title3":"Pediatric intracranial infections"},{"title3":"Fetal brain magnetic resonance imaging findings in congenital cytomegalovirus infection with postnatal imaging correlation"},{"title3":"Necrotic and apoptotic cells serve as nuclei for calcification on osteoblastic differentiation of human mesenchymal stem cells in vitro"},{"title3":"Zika virus impairs growth in human neurospheres and brain organoids"},{"title3":"Zika virus infects human cortical neural progenitors and attenuates their growth"},{"title3":"Brain-region-specific organoids using mini-bioreactors for modeling zikv exposure"},{"title3":"Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells"},{"title3":"Zika virus in Brazil and macular atrophy in a child with microcephaly"},{"title3":"Zika virus-associated microcephaly and eye lesions in the newborn"},{"title3":"Eye manifestations of intrauterine infections and their impact on childhood blindness"},{"title3":"Arthrogryposis: an update on clinical aspects, etiology, and treatment strategies"},{"title3":"Arthrogryposis: a review and update"},{"title3":"Teratogens associated with congenital contractures in humans and in animals"},{"title3":"Transplacental infection of coxsackievirus B3 pathological findings in the fetus"},{"title3":"Update: Interim guidance for the evaluation and management of infants with possible congenital Zika virus infection - United States, August 2016"},{"title3":"Sonographic findings in fetal viral infections: a systematic review"},{"title3":"Neuroradiologic patterns and novel imaging findings in Aicardi-Goutieres syndrome"},{"title3":"Band-like intracranial calcification with simplified gyration and polymicrogyria: a distinct &quot;pseudo-TORCH&quot; phenotype"},{"title3":"Recessive mutations in the gene encoding the tight junction protein occludin cause band-like calcification with simplified gyration and polymicrogyria"},{"title3":"A homozygous mutation in the tight-junction protein JAM3 causes hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts"},{"title3":"Deletion 16p13.11 uncovers NDE1 mutations on the non-deleted homolog and extends the spectrum of severe microcephaly to include fetal brain disruption"},{"title3":"A drosophila genetic resource of mutants to study mechanisms underlying human genetic diseases"},{"title3":"Fetal brain disruption sequence versus fetal brain arrest: A distinct autosomal recessive developmental brain malformation phenotype"},{"title3":"Fetal brain disruption sequence in sisters"},{"title3":"Hereditary fetal brain degeneration resembling fetal brain disruption sequence in two sibships"},{"title3":"Zika: neurological and ocular findings in infant without microcephaly"},{"title3":"Zika virus disease in Colombia - Preliminary report"},{"title3":"Lenticulostriated vasculopathy is a high-risk marker for hearing loss in congenital cytomegalovirus infections"},{"title3":"Congenital Zika syndrome: time to move from case series to case-control studies and data sharing"}]},{"title2":"Zika vrus and birth defects:reviewing the evidence for causality","References":[]},{"title2":"Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 2020;92:214-7.","References":[]},{"title2":"Coronavirus disease (COVID-19) outbreak","References":[]},{"title2":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group","References":[]},{"title2":"Severe acute respiratory syndrome: Historical, epidemiologic, and clinical features","References":[{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"List of blue print priority diseases"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November to 31 July 2003"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection"},{"title3":"Analysis on the characteristics of blood serum Ab-IgG detective result of severe acute respiratory syndrome patients in Guangzhou, China"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong province, China, 2003"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Persistent infection of SARS coronavirus in colonic cells in vitro"},{"title3":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells"},{"title3":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)"},{"title3":"Pegulated interferon-a protects type I pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"The membrane protein of severe acute respiratory syndrome coronavirus functions as a novel cytosolic pathogen-associated molecular pattern to promote beta interferon induction via a Toll-like-receptor-related TRAF3-independent mechanism"},{"title3":"IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese"},{"title3":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection"},{"title3":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome in Guangdong, People's Republic of China, in February 2003"},{"title3":"Severe acute respiratory syndrome"},{"title3":"The severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Index patient and SARS outbreak in Hong Kong"},{"title3":"The severe acute respiratory syndrome coronavirus in tears"},{"title3":"Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients"},{"title3":"Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong"},{"title3":"Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units"},{"title3":"Update 95-SARS: chronology of a serial killer"},{"title3":"Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?"},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review"},{"title3":"Viral load distribution in SARS outbreak"},{"title3":"Evidence of airborne transmission of the severe acute respiratory syndrome virus"},{"title3":"Severe acute respiratory syndrome beyond Amoy Gardens: completing the incomplete legacy"},{"title3":"Superspreading and the effect of individual variation on disease emergence"},{"title3":"Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"},{"title3":"Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome"},{"title3":"Possible central nervous system infection by SARS coronavirus"},{"title3":"Severe acute respiratory syndrome (SARS) in a geriatric patient with a hip fracture. A case report"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups"},{"title3":"SARS: clinical features and diagnosis"},{"title3":"Severe acute respiratory syndrome: correlation between clinical outcome and radiologic features"},{"title3":"Estimating variability in the transmission of severe acute respiratory syndrome to household contacts in Hong Kong, China"},{"title3":"Early diagnosis of SARS coronavirus infection by real time RT-PCR"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome"},{"title3":"Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Temporal patterns of hepatic dysfunction and disease severity in patients with SARS"},{"title3":"Thin section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicenter retrospective matched cohort study"},{"title3":"Interferon Alfacon-1 plus corticosteroids in severe acute respiratory syndrome. A preliminary study"},{"title3":"Hemophagocytic syndrome and infection"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"Effects of a SARS-associated coronavirus vaccine in monkeys"},{"title3":"DNA vaccine of SARS-CoV S gene induces antibody response in mice"},{"title3":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice"},{"title3":"Pandemic planning in China: applying lessons from severe acute respiratory syndrome"},{"title3":"Infection prevention and control measures for acute respiratory infections in healthcare settings: an update"}]},{"title2":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease","References":[{"title3":"Emergence of Zaire Ebola virus disease in Guinea"},{"title3":"Progress in global surveillance and response capacity 10 years after severe acute respiratory syndrome"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak"},{"title3":"Outbreak of tuberculosis among regular patrons of a neighborhood bar"},{"title3":"Cynomolgus macaque as an animal model for severe acute respiratory syndrome"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees"},{"title3":"Promedmail.org (2015). MERS-COV (97): South Korea, Saudi Arabia. International Society for Infectious Diseases."},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"MERS in South Korea and China: a potential outbreak threat?"},{"title3":"WHO (2015a). Middle East respiratory syndrome coronavirus (MERS-CoV) - Republic of Korea. Disease Outbreak News. 24 May 2015. http://www.who.int/csr/don/24-may-2015-mers-korea/en/."},{"title3":"WHO (2015b). Sierra Leone: a traditional healer and a funeral. http://www.who.int/csr/disease/ebola/ebola-6-months/sierra-leone/en/."},{"title3":"Ebola virus transmission in guinea pigs"}]},{"title2":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome","References":[{"title3":"World Health Organization. Severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/. Accessed June 15, 2003."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en/. Accessed June 15, 2003."},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"World Health Organization. Severe acute respiratory syndrome (SARS): laboratory diagnostic tests. Available at: http://www.who.int/csr/sars/diagnostictests/en/. Accessed October 15, 2003."},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Pneumonia in pregnancy"},{"title3":"Influenza occurring in pregnant women"},{"title3":"Maternal mortality in the epidemic of Asian influenza New York City 1957"},{"title3":"Pulmonary ventilation in pregnancy"},{"title3":"Incidence of early loss of pregnancy"},{"title3":"Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice"},{"title3":"Murine trophoblast failure and spontaneous abortion"},{"title3":"Teratogenic effects of ribavirin on hamster and rat embryos"},{"title3":"Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome?"},{"title3":"Antepartum pneumonia in pregnancy"},{"title3":"Altitude, low birth weight, and infant mortality in Colorado"},{"title3":"Infant birth weight is related to maternal arterial oxygenation at high altitude"}]},{"title2":"Infants born to mothers with severe acute respiratory syndrome","References":[]},{"title2":"SARS in newborns and children","References":[{"title3":"Alterations of immunoglobulin G and immunoglobulin M levels in the breast milk of mothers with exclusive breastfeeding compared to mothers with non-exclusive breastfeeding during 6 months postpartum: the Jordanian cohort study"},{"title3":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis"},{"title3":"SARS-CoV-2 antibodies detected in mother's milk post-vaccination"},{"title3":"Maternal and infant outcomes associated with maternity practices related to COVID-19: the COVID mothers study"},{"title3":"Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine"},{"title3":"Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns"},{"title3":"Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study"},{"title3":"Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review"},{"title3":"Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19"},{"title3":"COVID-19 mRNA vaccine and antibody response in lactating women: a prospective cohort study"},{"title3":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2"},{"title3":"Changes in human milk immunoglobulin profile during prolonged lactation"},{"title3":"Coronavirus disease-19 deaths among children and adolescents in an area of Northeast, Brazil: why so many?"},{"title3":"Impact of pertussis-specific IgA, IgM, and IgG antibodies in mother's own breast milk and donor breast milk during preterm infant digestion"},{"title3":"European Medicines Agency. Comirnaty. https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu https://www.ema.europa.eu/en/medicines/human/summaries-opinion/comirnaty, 2020 (accessed on 29 december 2020)."},{"title3":"Robust and specific secretory IgA against SARS-CoV-2 detected in human milk"},{"title3":"COVID-19 mRNA vaccination in lactation: assessment of adverse events and vaccine related antibodies in mother-infant dyads"},{"title3":"The immune system of human milk: antimicrobial, anti-inflammatory and immunomodulating properties"},{"title3":"Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination"},{"title3":"Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study"},{"title3":"Anti-idiotypic antibodies to poliovirus antibodies in commercial immunoglobulin preparations, human serum, and milk"},{"title3":"Hare H, Womersley K. Healthcare workers who breastfeed should be offered the Covid-19 vaccine. https://blogs.bmj.com/bmj/2020/12/21/healthcare-workers-who-breastfeed-should-be-offered-the-covid-19-vaccine, 2020 (accesed on 15 january 2021)."},{"title3":"Joint Committee on Vaccination and Immunisation. COVID-19 vaccination: a guide for women of childbearing age, pregnant or breastfeeding, Updated 2021. https://www.gov.uk/government/publications/covid-19-vaccination-women-of-childbearing-age-currently-pregnant-planning-a-pregnancy-or-breastfeeding, 2021 (accesed on january 2022)."},{"title3":"Vertical transmission of Coronavirus disease 2019: a systematic review and meta-analysis"},{"title3":"No infectious SARS-CoV-2 in breast milk from a cohort of 110 lactating women"},{"title3":"Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis"},{"title3":"Correction to: SARS-COV-2 infection in children and newborns: a systematic review"},{"title3":"Breast milk prefusion F Immunoglobulin G as a correlate of protection against respiratory syncytial virus acute respiratory illness"},{"title3":"Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019-positive mothers and neonates at birth"},{"title3":"SARS-CoV-2-specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women"},{"title3":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine"},{"title3":"IgA and neutralizing antibodies to influenza A virus in human milk: a randomized trial of antenatal influenza immunization"},{"title3":"Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized, controlled evaluation"},{"title3":"IgA dominates the early neutralizing antibody response to SARS-CoV-2"},{"title3":"Induction of mucosal immunity through systemic immunization: phantom or reality?"},{"title3":"Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age"},{"title3":"The Advisory Committee on Immunization Practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in children aged 5-11 years - United States, November 2021"}]},{"title2":"Emergency cesarean section in an epidemic of the middle east respiratory syndrome: a case report","References":[{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Middle East respiratory syndrome coronavirus in healthcare settings"},{"title3":"A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system"},{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus"},{"title3":"Abruptio placentae. Diagnosis, management and maternal-fetal prognosis: a retrospective study of 100 cases"},{"title3":"Mode of anaesthetic for category 1 caesarean sections and neonatal outcomes"},{"title3":"Anesthetic practice for Caesarean section and factors influencing anesthesiologists' choice of anesthesia: a population-based study"},{"title3":"Infection control measures for operative procedures in severe acute respiratory syndromerelated patients"},{"title3":"Lack of Transmission among Close Contacts of Patient with Case of Middle East Respiratory Syndrome Imported into the United States, 2014"},{"title3":"Severe acute respiratory syndrome in pregnancy"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS)"},{"title3":"Conversion of operating theatre from positive to negative pressure environment"},{"title3":"N95 respirator use during advanced pregnancy"},{"title3":"Acute and chronic respiratory diseases in pregnancy: associations with placental abruption"}]},{"title2":"A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Severe Acute Respiratory Syndrome (SARS)"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Severe acute respiratory syndrome and pregnancy"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"SARS bulletin from Hong Kong: what might we have done better"},{"title3":"Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"The severe acute respiratory syndrome"},{"title3":"Pneumonia in pregnancy"},{"title3":"Influenza occurring in pregnant women"},{"title3":"Maternal mortality in the epidemic of Asian influenza New York City 1957"},{"title3":"Pneumonia complicating pregnancy"},{"title3":"Physiological response to pregnancy at rest and during exercise"},{"title3":"Cell-mediated immunity and pregnancy"},{"title3":"Pulmonary ventilation in pregnancy"},{"title3":"Center of Disease Control and Prevention. Frequently asked question: is the use of ribavirin (or other antiviral drugs) effective in the treatment of patients with SARS"},{"title3":"Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice"},{"title3":"Teratogenic effects of ribavirin on hamster and rat embryos"},{"title3":"Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto Area"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"}]},{"title2":"SARS and pregnancy: a case report","References":[]},{"title2":"SARS during pregnancy, United States","References":[]},{"title2":"Severe acute respiratory syndrome in pregnancy","References":[]},{"title2":"Specific immunoglobulin g antibody detected in umbilical blood and amniotic fluid from a pregnant woman infected by the coronavirus associated with severe acute respiratory syndrome","References":[]},{"title2":"Possible central nervous system infection by SARS coronavirus","References":[{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong."},{"title3":"Relationships between magnesium and protein concentrations in serum."},{"title3":"Hypomagnesemic disorders."},{"title3":"Pre-eclampsia."},{"title3":"Human coronavirus: a brief review."},{"title3":"Human coronavirus HCoV-229E enters susceptible cells via the endocytic pathway."},{"title3":"Human coronavirus gene expression in the brains of multiple sclerosis patients."},{"title3":"Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients."},{"title3":"Persistent infection of neural cell lines by human coronaviruses."},{"title3":"Neuroinvasion by human respiratory coronaviruses."}]},{"title2":"The effect of Severe Acute Respiratory Syndrome on a hospital obstetrics and gynaecology service","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"SARS: experience at Prince of Wales Hospital, Hong Kong"}]},{"title2":"Managing obstetrical patients during severe acute respiratory syndrome outbreak","References":[{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"A major outbreak of Severe Acute Respiratory Syndrome in Hong Kong"},{"title3":"Coronavirus as possible cause of Severe Acute Respiratory Syndrome"},{"title3":"Development of a standard treatment protocol for Severe Acute Respiratory Syndrome"},{"title3":"Control measures for Severe Acute Respiratory Syndrome (SARS) in Taiwan"},{"title3":"Severe Acute Respiratory Syndrome (SARS) in Singapore: clinical features of index patient and initial contacts"},{"title3":"Identification of Severe Acute Respiratory Syndrome in Canada"},{"title3":"Epidemiology, clinical presentation and laboratory investigation of Severe Acute Respiratory Syndrome (SARS) in Canada"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Clinical course and management of SARS in health care workers in Toronto: a case series"},{"title3":"Health Canada. SARS clinical decision guide: case definitions. Available at wwwhc-sc.gc.ca/pphb-dgspsp/sars-sras/, accessed June 16, 2003."},{"title3":"Severe Acute Respiratory Syndrome: Providing care in the face of uncertainty"},{"title3":"Identification and containment of an outbreak of SARS in a community hospital"},{"title3":"Cluster of Severe Acute Respiratory Syndrome cases among protected health care workers-Toronto, April 2003"},{"title3":"Guideline on management of Severe Acute Respiratory Syndrome (SARS)"}]},{"title2":"First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities, May 2014","References":[]},{"title2":"Middle East respiratory syndrome (MERS)","References":[]},{"title2":"Worldwide reduction in MERS cases and deaths since 2016","References":[{"title3":". Middle East respiratory syndrome coronavirus (MERS-CoV) [cited 2019 June 4]. http://www.who.int/emergencies/mers-cov"},{"title3":"MERS: Progress on the global response, remaining challenges and the way forward."},{"title3":"2015 MERS outbreak in Korea: hospital-to-hospital transmission."},{"title3":"2014 MERS-CoV outbreak in Jeddah:a link to health care facilities."},{"title3":"Notes from the field: nosocomial outbreak of Middle East respiratory syndrome in a large tertiary care hospital:Riyadh, Saudi Arabia, 2015."},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus."},{"title3":"Comparative analysis of eleven healthcare-associated outbreaks of MERS-CoV from 2015-2017."},{"title3":". Middle East respiratory syndrome coronavirus (MERS-CoV) [cited 2019 Jun 4]. http://www.who.int/emergencies/mers-cov"},{"title3":". Middle East respiratory syndrome coronavirus (MERS-CoV) infection-Republic of Korea [cited 2019 Jun 4]. http://www.who.int/csr/don/12-september-2018-mers-republic-of-korea"}]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases and review of the literature","References":[{"title3":"Emergency cesarean section in an epidemic of the Middle East respiratory syndrome: a case report"},{"title3":"Middle East respiratory syndrome coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia"},{"title3":"Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome"},{"title3":"Middle East respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013"},{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus"},{"title3":"MERS-CoV infection in a pregnant woman in Korea"}]},{"title2":"Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome","References":[{"title3":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) - Saudi Arabia. http://www.who.int/csr/don/21-august-2015-mers-saudi-arabia/en/ (Accessed on August 24, 2015)"},{"title3":"The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957-1958"},{"title3":"2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome"},{"title3":"Pandemic (H1N1) 2009 in Neonates, Japan"},{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus"},{"title3":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literatureupdate- As of 20 January 2014. http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_Update_20_Jan_2014.pdf (Accessed on January 29, 2014)."},{"title3":"Corman VM, Muller MA, Costabel U, Timm J, Binger T, Meyer B, Kreher P, Lattwein E, Eschbach-Bludau M, Nitsche A, Bleicker T, Landt O, Schweiger B, Drexler JF, Osterhaus AD, Haagmans BL, Dittmer U, Bonin F, Wolff T, Drosten C. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012 Dec 6;17(49). pii: 20334"},{"title3":"Pneumonia in pregnancy"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"SARS-CoV infection and pregnancy"}]},{"title2":"Middle East respiratory syndrome coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia","References":[{"title3":"MERS situation update: 30 November 2015"},{"title3":"2014 MERS-CoV outbreak in Jeddah:a link to health care facilities"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013"},{"title3":"Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States"},{"title3":"Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis"},{"title3":"Pregnancy and the lung"},{"title3":"Health requirements and recommendations for Hajj and Umrah performers and those working in Hajj areas:2015"}]},{"title2":"Middle East respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013","References":[{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus."},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection."},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia."},{"title3":"Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study."},{"title3":"Emerging infections and pregnancy."},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome."},{"title3":"SARS during pregnancy, United States."},{"title3":"Pregnancy and infection."},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study."},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections."},{"title3":"Still learning from SARS."},{"title3":"Taking stock of the first 133 MERS coronavirus cases globally:is the epidemic changing?"},{"title3":" COPEGUS (ribavirin) tablets: highlights of prescribing information. Reference ID: 3004561 [cited 2015 Dec 8]. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021511s023lbl.pdf"},{"title3":"Common adverse events associated with the use of ribavirin for SARS in Canada."}]},{"title2":"Stillbirth during infection with Middle East respiratory syndrome coronavirus","References":[{"title3":"Update: severe respiratory illness associated with a novel coronavirus--worldwide, 2012-2013"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Global Alert and Response. Revised interim case definition for reporting to WHO:Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Management guidelines for obstetric patients and neonates born to mothers with suspected or probable Severe Acute Respiratory Syndrome (SARS)"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Obstetric, clinical and perinatal implications of H1N1 viral infection during pregnancy"},{"title3":"Pneumonia in pregnancy"},{"title3":"Pregnancy-associated depression of cell-mediated immunity"},{"title3":"Changes in pulmonary function during pregnancy: A longitudinal cohort study"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"},{"title3":"Age-specific risk of fetal loss observed in a second trimester serum screening population"},{"title3":"Novel human coronavirus not detected in children hospitalized with acute respiratory illness in Amman, Jordan, March 2010-September 2012"},{"title3":"Kingdom of Saudi Arabia, Ministry of Health. Press release"}]},{"title2":"Contact tracing the first Middle East respiratory syndrome case in the Philippines, February 2015","References":[]},{"title2":"MERS-CoV infection in a pregnant woman in Korea","References":[{"title3":"The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957-1958"},{"title3":"MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study"},{"title3":"2015 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) nosocomial outbreak in South Korea: insights from modeling"},{"title3":"Serologic evaluation of MERS screening strategy for healthcare personnel during a hospital-associated outbreak"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Characteristics and outcomes of Middle East Respiratory Syndrome Coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia"},{"title3":"Clinical presentation and outcomes of Middle East Respiratory Syndrome in the Republic of Korea"},{"title3":"2015 MERS outbreak in Korea: hospital-to-hospital transmission"},{"title3":"Better understanding on MERS Corona Virus outbreak in Korea"},{"title3":"Case definition and management of patients with MERS Coronavirus in Saudi Arabia"},{"title3":"Impact of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) on pregnancy and perinatal outcome"},{"title3":"Middle East Respiratory Syndrome Coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia"},{"title3":"Middle East Respiratory Syndrome Coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013"},{"title3":"Stillbirth during infection with Middle East Respiratory Syndrome Coronavirus"},{"title3":"Transmission of MERS-coronavirus in household contacts"},{"title3":"Persistence of antibodies against Middle East Respiratory Syndrome Coronavirus"},{"title3":"Middle East Respiratory Syndrome Coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control"},{"title3":"The emergence of the Middle East Respiratory Syndrome Coronavirus"}]},{"title2":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.","References":[]},{"title2":"Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199-207.","References":[]},{"title2":"Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33.","References":[]},{"title2":"Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-74.","References":[]},{"title2":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-13.","References":[]},{"title2":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, in press.","References":[]},{"title2":"Report 4: severity of 2019-novel coronavirus (nCoV). WHO Collaborating Centre for Infectious Disease Modelling, MRC Centre for Global Infectious Disease Analysis, Imperial College London","References":[]},{"title2":"Shen KL, Yang YH. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue. World J Pediatr, in press.","References":[]},{"title2":"Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020;382:929-36.","References":[]},{"title2":"Evidence of airborne transmission of the severe acute respiratory syndrome virus","References":[]},{"title2":"Chen J. Pathogenicity and transmissibility of 2019-nCoV:a quick overview and comparison with other emerging viruses. Microbes Infect 2020;22:69-71.","References":[]},{"title2":"Pregnant women and the Ebola crisis","References":[]},{"title2":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Notice on prevention and control of pneumonia in children and pregnant women with new coronavirus infection"},{"title3":"New coronavirus pneumonia prevention and control program (4th edn)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"The Spanish flu in Iceland 1918. Lessons in medicine and history"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Novel 2019 coronavirus genome"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Rubella and pregnancy: diagnosis, management and outcomes"},{"title3":"Wuhan Tongji Hospital diagnoses first case of neonatal infection with new coronavirus"},{"title3":"Neonatal coronavirus expert confirmed at 30 hours of birth: vertical transmission from mother to infant"}]},{"title2":"Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020;9:51-60.","References":[]},{"title2":"Paules CI, Marston HD, Fauci AS. Coronavirus infections:more than just the common cold. JAMA, in press.","References":[]},{"title2":"Extracorporeal membrane oxygenation (ECMO) during pregnancy and postpartum","References":[]},{"title2":"Management of acute respiratory failure in pregnancy","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"Can coronavirus pass from mother to baby? Maybe, but experts need more research. Global news","References":[]},{"title2":"Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newborns","References":[]},{"title2":"Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virol 2020 Mar 17;94(7).","References":[]},{"title2":"Interim infection prevention and control recommendations for patients with confirmed 2019 novel coronavirus (2019-nCoV) or patients under investigation for 2019-nCoV in healthcare settings. Centers for Disease Control and Prevention. Updated Feb. 3, 2020","References":[]},{"title2":"Interim guidance for implementing home care of people not requiring hospitalization for 2019 novel coronavirus (2019-nCoV). Updated Jan. 31, 2020","References":[]}]},{"title1":"Multisystem Inflammatory Syndrome in Children in New York State","References":[{"title2":"COVID-19 testing, epidemic features, hospital outcomes, and household prevalence, New York State : March 2020.","References":[]},{"title2":". COVID-19 United States Cases 2020 ().","References":[]},{"title2":"Epidemiology of COVID-19 among children in China.","References":[{"title3":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 83 [press release]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200412-sitrep-83-covid-19.pdf?sfvrsn=697ce98d_4. Accessed April 12, 2020."},{"title3":"Epidemiology of COVID-19 among children in China"},{"title3":"Control and Prevention. Coronavirus Disease 2019 in Children : United States, February 12-April 2, 2020"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"SARS-CoV-2 infection in children"},{"title3":"Detection of COVID-19 in children in early January 2020 in Wuhan, China"},{"title3":"Novel coronavirus infection in hospitalized infants under 1 year of age in China"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"A 55-day-old female infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage"},{"title3":"Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children"},{"title3":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus Disease 2019 : COVID-NET, 14 states, March 1-30, 2020.","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"The US Influenza Hospitalization Surveillance Network."},{"title3":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 : United States, February 12-March 28, 2020."},{"title3":"Estimating influenza disease burden from population-based surveillance data in the United States."}]},{"title2":"Coronavirus disease 2019 in children : United States, February 12-April 2, 2020.","References":[{"title3":"SARS-CoV-2 infection in children."},{"title3":"Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China."},{"title3":"Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China."},{"title3":"Presymptomatic transmission of SARS-CoV-2:Singapore, January 23-March 16, 2020"},{"title3":" Severe outcomes among patients with coronavirus disease 2019 (COVID-19):United States, February 12-March 16, 2020."},{"title3":"Evaluation of the effectiveness of surveillance and containment measures for the first 100 patients with COVID-19 in Singapore:January 2-February 29, 2020."},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19):China, 2020."}]},{"title2":"COVID-19 and Kawasaki disease: novel virus and novel case.","References":[]},{"title2":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.","References":[{"title3":"Nuovo coronavirus: cosa c'e da sapere"},{"title3":"Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection"},{"title3":"Epidemiology of COVID-19 among children in China"},{"title3":"A pediatric emergency department protocol to avoid intra-hospital dispersal of SARS-CoV-2 during the outbreak in Bergamo, Italy"},{"title3":"Evidence for gastrointestinal infection of SARS-CoV-2"},{"title3":"On the alert for cytokine storm: immunopathology in COVID-19"},{"title3":"Coronaviruses and immunosuppressed patients. The facts during the third epidemic"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan"},{"title3":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients"},{"title3":"Recognition of a Kawasaki disease shock syndrome"},{"title3":"Macrophage activation syndrome in Kawasaki disease: more common than we thought?"},{"title3":"Is Kawasaki disease an infectious disorder?"},{"title3":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association"},{"title3":"2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative"},{"title3":"Kawasaki disease complicated with macrophage activation syndrome: a systematic review"},{"title3":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial"},{"title3":"Kawasaki disease: insights into pathogenesis and approaches to treatment"},{"title3":"Kawasaki disease: epidemiology and the lessons from it"},{"title3":"Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey"},{"title3":"Update on Kawasaki disease: epidemiology, aetiology and pathogenesis"},{"title3":"Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey"},{"title3":"The genetics of Kawasaki disease"},{"title3":"Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007"},{"title3":"Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase"},{"title3":"Association between a novel human coronavirus and Kawasaki disease"},{"title3":"Coronaviruses in the limelight"},{"title3":"Lack of association between New Haven coronavirus and Kawasaki disease"},{"title3":"Reply to van der Hoek and Berkhout, Ebihara et al., and Belay et al"},{"title3":"Concurrent respiratory viruses and Kawasaki disease"},{"title3":"Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease"},{"title3":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease"},{"title3":"COVID-19 in children and altered inflammatory responses"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"}]},{"title2":"Hyperinflammatory shock in children during COVID-19 pandemic.","References":[{"title3":"Clinical analysis of Kawasaki disease shock syndrome"},{"title3":"The science underlying COVID-19: implications for the cardiovascular system"},{"title3":"Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN- as biomarkers for early recognition"}]},{"title2":"Centers for Disease Control and Prevention. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). May 14, 2020 ().","References":[]},{"title2":"NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies.","References":[]},{"title2":"Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units.","References":[]},{"title2":"Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic.","References":[]},{"title2":"Characteristics, cardiac involvement, and outcomes of multisystem inflammatory disease of childhood (MIS-C) associated with SARS-CoV-2 infection.","References":[]},{"title2":"Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases.","References":[]},{"title2":"Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City.","References":[]},{"title2":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.","References":[]},{"title2":"Kawasaki disease in a pediatric intensive care unit: a case-control study.","References":[]},{"title2":"Adult-onset Kawasaki disease (mucocutaneous lymph node syndrome) and concurrent Coxsackievirus A4 infection: a case report.","References":[{"title3":"Acute febrile muco-cutaneous lymph node syndrome in young children with unique digital desquamation"},{"title3":"Nationwide survey on Kawasaki disease in Japan"},{"title3":"Kawasaki syndrome: critical review of US epidemiology"},{"title3":"Adult Kawasaki disease. Report of two cases treated with intravenous gamma globulin"},{"title3":"Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus"},{"title3":"Development of serum IgM antibodies against super antigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease"},{"title3":"Association between a novel human coronavirus and Kawasaki disease"},{"title3":"Adult Kawasaki disease: report of two cases and literature review"},{"title3":"Center for Disease Control (CDC) case definition for Kawasaki syndrome"},{"title3":"Kawasaki disease in adults: report of 10 cases"},{"title3":"The role of infection in Kawasaki syndrome"},{"title3":"Seasonality and temporal clustering of Kawasaki syndrome"},{"title3":"Kawasaki syndrome and concurrent Coxsackie virus B3 infection"},{"title3":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association"},{"title3":"Diagnosis and therapy of Kawasaki disease in children"},{"title3":"Use of intravenous gamma-globulin for Kawasaki disease: effects on cardiac sequelae"},{"title3":"Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research"}]},{"title2":"Characteristics and clinical outcomes of adult patients hospitalized with COVID-19 : Georgia, March 2020.","References":[{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"Research electronic data capture (REDCap):a metadata-driven methodology and workflow process for providing translational research informatics support."},{"title3":"Covid-19 in critically ill patients in the Seattle region:case series."},{"title3":"Community mitigation guidelines to prevent pandemic influenza:United States, 2017."},{"title3":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019:COVID-NET, 14 states, March 1-30, 2020."}]},{"title2":". Vintage 2018 bridged-race population estimates ().","References":[]},{"title2":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.","References":[{"title3":"A review of studies on animal reservoirs of the SARS coronavirus"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis"},{"title3":"Coronavirus disease 2019 (COVID-19): situation report:41"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"The remaining challenge of pneumonia: the leading killer of children"},{"title3":"Child pneumonia at a time of epidemiological transition"},{"title3":"Severe acute respiratory syndrome among children"},{"title3":"Middle East respiratory syndrome coronavirus disease is rare in children: an update from Saudi Arabia"},{"title3":"Analysis of CT features of 15 children with 2019 novel coronavirus infection"},{"title3":"Diagnosis and treatment guidelines for 2019 novel coronavirus pneumonia (draft version 5)"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Novel primers and probes for detection of novel coronavirus 2019"},{"title3":"Diagnosis and treatment recommendation for pediatric coronavirus disease-19"},{"title3":"Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Severe acute respiratory syndrome (SARS): chest radiographic features in children"},{"title3":"Clinical features of 167 children with the novel influenza A (H1N1) virus infection in Xi'an, China"},{"title3":"An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov)"},{"title3":"Pneumonia: the leading killer of children"},{"title3":"Biomarkers for pediatric sepsis and septic shock"},{"title3":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients"}]}]}]}